279 related articles for article (PubMed ID: 23511364)
1. Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study.
Barbieri A; Giuliani E; Carone C; Pederzoli F; Mascheroni G; Greco G; Stucchi C; Genedani S
Minerva Anestesiol; 2013 Jul; 79(7):750-7. PubMed ID: 23511364
[TBL] [Abstract][Full Text] [Related]
2. A biomarker panel: an additional resource in acute stroke evaluation?
Kimura T; Nishikawa T
Minerva Anestesiol; 2013 Jul; 79(7):711-2. PubMed ID: 23558768
[No Abstract] [Full Text] [Related]
3. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study.
Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J
Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke.
Tu WJ; Dong X; Zhao SJ; Yang DG; Chen H
J Neuroendocrinol; 2013 Sep; 25(9):771-8. PubMed ID: 23701638
[TBL] [Abstract][Full Text] [Related]
5. Discriminative capacity of biomarkers for acute stroke in the emergency department.
Glickman SW; Phillips S; Anstrom KJ; Laskowitz DT; Cairns CB
J Emerg Med; 2011 Sep; 41(3):333-9. PubMed ID: 20417054
[TBL] [Abstract][Full Text] [Related]
6. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of combined NT-pro-BNP levels and NIHSS scores in patients with acute ischemic stroke.
Chen X; Zhan X; Chen M; Lei H; Wang Y; Wei D; Jiang X
Intern Med; 2012; 51(20):2887-92. PubMed ID: 23064562
[TBL] [Abstract][Full Text] [Related]
8. Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome.
Montaner J; García-Berrocoso T; Mendioroz M; Palacios M; Perea-Gainza M; Delgado P; Rosell A; Slevin M; Ribó M; Molina CA; Alvarez-Sabín J
Cerebrovasc Dis; 2012; 34(3):240-5. PubMed ID: 23018289
[TBL] [Abstract][Full Text] [Related]
9. Could pro-BNP, uric acid, bilirubin, albumin and transferrin be used in making the distinction between stroke subtypes?
Cojocaru IM; Cojocaru M; Sapira V; Ionescu A; Bârlan S; Tacu N
Rom J Intern Med; 2013; 51(3-4):188-95. PubMed ID: 24620632
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study.
Laskowitz DT; Kasner SE; Saver J; Remmel KS; Jauch EC;
Stroke; 2009 Jan; 40(1):77-85. PubMed ID: 18948614
[TBL] [Abstract][Full Text] [Related]
11. A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department.
Montaner J; Mendioroz M; Ribó M; Delgado P; Quintana M; Penalba A; Chacón P; Molina C; Fernández-Cadenas I; Rosell A; Alvarez-Sabín J
J Intern Med; 2011 Aug; 270(2):166-74. PubMed ID: 21198992
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke.
Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL
Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.
Hajsadeghi S; Kashani Amin L; Bakhshandeh H; Rohani M; Azizian AR; Jafarian Kerman SR
J Stroke Cerebrovasc Dis; 2013 May; 22(4):554-60. PubMed ID: 23422348
[TBL] [Abstract][Full Text] [Related]
14. Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke.
An SA; Kim J; Kim OJ; Kim JK; Kim NK; Song J; Oh SH
Clin Biochem; 2013 Jun; 46(9):710-5. PubMed ID: 23462697
[TBL] [Abstract][Full Text] [Related]
15. S100β Protein as a Predictor of Poststroke Functional Outcome: A Prospective Study.
Branco JP; Oliveira S; Sargento-Freitas J; Santos Costa J; Cordeiro G; Cunha L; Freire Gonçalves A; Pinheiro J
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1890-1896. PubMed ID: 29571758
[TBL] [Abstract][Full Text] [Related]
16. Serum protein S100β is a diagnostic biomarker for distinguishing posterior circulation stroke from vertigo of nonvascular causes.
Purrucker JC; Herrmann O; Lutsch JK; Zorn M; Schwaninger M; Bruckner T; Auffarth GU; Veltkamp R
Eur Neurol; 2014; 72(5-6):278-84. PubMed ID: 25323105
[TBL] [Abstract][Full Text] [Related]
17. Brain natriuretic peptide in acute ischemic stroke.
Maruyama K; Shiga T; Iijima M; Moriya S; Mizuno S; Toi S; Arai K; Ashihara K; Abe K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(5):967-72. PubMed ID: 24119617
[TBL] [Abstract][Full Text] [Related]
18. Neural damage biomarkers during open carotid surgery versus endovascular approach.
Giuliani E; Genedani S; Moratto R; Veronesi J; Carone C; Bonvecchio C; Mosca F; Coppi G; Barbieri A
Ann Vasc Surg; 2014 Oct; 28(7):1671-9. PubMed ID: 24911800
[TBL] [Abstract][Full Text] [Related]
19. Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagic-ischemic stroke.
Kavalci C; Genchallac H; Durukan P; Cevik Y
Bratisl Lek Listy; 2011; 112(7):398-401. PubMed ID: 21744736
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke.
Giannakoulas G; Hatzitolios A; Karvounis H; Koliakos G; Charitandi A; Dimitroulas T; Savopoulos C; Tsirogianni E; Louridas G
Angiology; 2005; 56(6):723-30. PubMed ID: 16327949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
